Impact of Macrophage Activity Modulation on the Status of Insulinocytes at Modeling of Diabetes Mellitus 2 Type

Chereshnev, V.; Belousova, A.; Sokolova, K.; Danilova, I.; Gette, I.

doi:10.31857/S102872210002674-6

Home

Rossiiskii immunologicheskii zhurnal

Issue 4

Impact of Macrophage Activity Modulation on the Status of Insulinocytes at Modeling of Diabetes Mellitus 2 Type

Annotation
Reviews
References

Impact of Macrophage Activity Modulation on the Status of Insulinocytes at Modeling of Diabetes Mellitus 2 Type

PII

S102872210002674-6-1

DOI

10.31857/S102872210002674-6

Publication type

Article

Status

Published

Authors

V. Chereshnev

Affiliation:

A. Belousova

Affiliation:

K. Sokolova

Affiliation:

I. Danilova

Affiliation:

I. Gette

Affiliation:

Journal name

Rossiiskii immunologicheskii zhurnal

Edition

Volume 12 Issue 4

Pages

782-784

Abstract

Keywords

Received

29.01.2019

Publication date

31.01.2019

Cite Download pdf To download PDF you should sign in

GOST	Chereshnev V., Belousova A., Sokolova K., Danilova I., Gette I. Impact of Macrophage Activity Modulation on the Status of Insulinocytes at Modeling of Diabetes Mellitus 2 Type // Rossiiskii immunologicheskii zhurnal – 2018. – V. 12. – Issue 4 C. 782-784 [Electronic resource]. URL: http://ras.jes.su/ruimm/s207987840001784-1-1-en (circulation date: 03.05.2024). DOI: 10.31857/S102872210002674-6
MLA	Chereshnev, V., Belousova, A., Sokolova, K., Danilova, I., Gette, I. "Impact of Macrophage Activity Modulation on the Status of Insulinocytes at Modeling of Diabetes Mellitus 2 Type." Rossiiskii immunologicheskii zhurnal 12.4 (2018):782-784. DOI: 10.31857/S102872210002674-6
APA	Chereshnev V., Belousova A., Sokolova K., Danilova I., Gette I. (2018). Impact of Macrophage Activity Modulation on the Status of Insulinocytes at Modeling of Diabetes Mellitus 2 Type. Rossiiskii immunologicheskii zhurnal 12(4), pp.782-784 DOI: 10.31857/S102872210002674-6

Размещенный ниже текст является ознакомительной версией и может не соответствовать печатной

Readers community rating: votes 0

1. Blinkova N. B., Danilova I. G., Gette I. F., Bulavintseva T. S. Reaktsiya immunokompetentnykh kletok na strukturnye povrezhdeniya pochki pri ehksperimental'nom alloksanovom diabete // Rossijskij immunologicheskij zhurnal. 2017, T. 11 (20), № 2. S. 257–258. [Blinkova N. B., Danilova I. G., Gette I. F., Bulavintseva T. S. Reaction of immunocompetent cells for structural kidney injuries at experimental alloxan diabetes // Russian Journal of Immunology. 2017, Vol. 11 (20), № 2. P. 257–258].

2. Spasov A. A., Voronkova M. P., Singur G. L., Cheplyaeva N. I., Chepurnova M. V. Ehksperimental'naya model' sakharnogo diabeta tipa 2 // Biomeditsina. № 3. 2011. S. 12–18. [Spasov A. A., Voronkova M. P., Singur G. L., Cheplyaeva N. I., Chepurnova M. V. Experimental model of diabetes mellitus type 2 // Biomedicine. № 3. 2011. P. 12–18].

3. Danilova I. G., Bulavintceva T. S., Gette I. F., Medvedeva S. Y., Emelyanov V. V., Abidov M. T. Partial recovery from alloxan-induced diabetes by sodium phthalhydrazide in rats //Biomed Pharmacother. 2017. 21(95). P. 103–110.

4. Mezza T., Kulkarni R. N. The regulation of pre- and post-maturational plasticity of mammalian islet cell mass// Diabetologia. 2014. 57(7). P. 1291–303.

5. Sarapultsev A., Gette I., Abidov M., Sarapultsev P., Chupakhin O., & Danilova I. (2014). Eff ect of immune modulators on the activity of enzymes after experimental myocardial infarction (832.10). The FASEB Journal, 28(1 Supplement), 832–10.